4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-007740
Chief Scientific Officer acquired 22,744 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fisher Stewart Chief Scientific Officer | 2020-12-11 | Option exercise | +4,743 | $2.11 | $10,008 | 90,115 | D |
| Fisher Stewart Chief Scientific Officer | 2020-12-11 | Option exercise | +9,701 | $3.71 | $35,991 | 99,816 | D |
| Fisher Stewart Chief Scientific Officer | 2021-02-03 | Option exercise | +2,371 | $2.11 | $5,003 | 102,187 | D |
| Fisher Stewart Chief Scientific Officer | 2021-02-03 | Option exercise | +5,929 | $3.71 | $21,997 | 108,116 | D |
| Derivatives | |||||||
| Fisher Stewart Chief Scientific Officer | 2020-12-11 | Option exercise · Stock Option (Right to Buy) | −4,743 | 4,742 | D | ||
| Fisher Stewart Chief Scientific Officer | 2020-12-11 | Option exercise · Stock Option (Right to Buy) | −9,701 | 61,443 | D | ||
| Fisher Stewart Chief Scientific Officer | 2021-02-03 | Option exercise · Stock Option (Right to Buy) | −2,371 | 2,371 | D | ||
| Fisher Stewart Chief Scientific Officer | 2021-02-03 | Option exercise · Stock Option (Right to Buy) | −5,929 | 55,514 | D | ||
Loading xslF345X03/doc4.xml…